Corvus Pharmaceuticals, Inc. (CRVS)
14.82
+0.13
(+0.88%)
USD |
NASDAQ |
Apr 06, 13:23
Corvus Pharmaceuticals EPS Diluted (Quarterly) : -0.1485 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Plus Therapeutics, Inc. | -1.03 |
| Geron Corp. | -0.0467 |
| Nektar Therapeutics | -1.778 |
| Jaguar Health, Inc. | -6.280 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.32M |
| Total Expenses (Quarterly) | 12.32M |
| Enterprise Value | 1.178B |
| Earnings Yield | -3.41% |
| Normalized Earnings Yield | -5.117 |